Simeone et al. found elevated CEACAM1 in serological samples of 195 patients (81 patients with pancreatic adenocarcinoma, 53 with chronic pancreatitis, and 61 healthy controls) compared to the other patients. The gene discussed is CEACAM1; the disease is pancreatic adenocarcinoma.